Ginsenoside Rg1 ameliorates glomerular fibrosis in type 2 diabetic mice by inhibiting the RPC2/NFAT2 signaling-dependent TGF-β1/Smad2/3 pathways (99). The gene discussed is TGFB1; the disease is type 2 diabetes mellitus.